Observational studyAdvances in therapy2025

One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis.

Piergiacomo Calzavara-Pinton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.